Reimex Pharma – Gold Sponsor of the 5th Scientific Conference "GENETICS IN CLINICAL PRACTICE"!

viber_image_2025-06-11_10-19-26-294

Reimex Pharma had the honor of being a Gold Sponsor of the 5th Scientific Conference on Genetics, which brought together leading specialists from across the country.

The conference featured a rich program, knowledge exchange, and presentations of the latest advancements in the field of genetics – an area that Reimex Pharma approaches with special interest and responsibility.

We are truly delighted to support the scientific community and invest in the advancement of innovation in healthcare.

Our sincere thanks to the organizers for the wonderful event, and to all participants for the inspiring lectures and discussions! We look forward to our next meetings!

Прочетете повече за Reimex Pharma

Reimex Pharma – Gold Sponsor of the 5th Scientific Conference "GENETICS IN CLINICAL PRACTICE"!

Reimex Pharma had the honor of being a Gold Sponsor of the 5th Scientific Conference on Genetics, which brought together leading specialists from across the country.

OUR GOAL IS TO HELP OVERCOME CHALLENGES

Two years after the establishment of the Association of Importers of Unlicensed Medicinal Products…

Training on "Contemporary Protocols in Dental Implantology" Successfully Completed!

On April 5, 2025, a one-day specialized course brought together nearly 30 motivated participants – dentists and dental medicine students…

REIMEX PHARMA has been recognized as one of the fast-growing companies in the Pharmacy and Beauty segment in Bulgaria

When you hear hoofbeats, think horses, not zebras!

This phrase is one that many doctors learn during medical school, reminding them that when diagnosing patient symptoms, they should first consider…

World Orphan Drug Congress Europe 2024

Reimex Pharma presented LYRA ETK Bulgaria at Sofia Dental Meeting 2024

Scientific symposium on the topic: "Diagnostic and therapeutic options in Alagille syndrome"

First Scientific Conference “Genetics in Clinical Practice”

Participation in the Balkan Endovascular Congress in Sofia